D-0692-2026 Class I Ongoing

Recalled by Blaine Labs Inc — Santa Fe Springs, CA

FDA drug recall D-0692-2026 was initiated by Blaine Labs Inc on Apr 8, 2026 and is designated Class I. Reason for recall: Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp The recall status is ongoing. Affected quantity: 1,171 - 1 oz bottles.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Apr 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,171 - 1 oz bottles

Product description

Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufactured By: Blaine Labs, Inc. 11037 Lockport Place Santa Fe Springs, CA 90670, NDC 63347-120-02.

Reason for recall

Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

Distribution pattern

Nationwide in the USA

Code information

Lot#: BL3608, Exp. 07/01/28.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0692-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0692-2026. Report a data issue: hello@regdatalab.com.